Table 1. Comparison of baseline characteristics between patients with and without complete follow-up data.
| Characteristics | Patients with complete follow-up data (n = 1713) | Patients without complete follow-up data (n = 593) | P |
| Age, y, mean±SD | 61.5±11.6 | 61.4±12.1 | 0.96 |
| Female (%) | 34.4 | 32.0 | 0.29 |
| History diabetes (%) | 22.9 | 24.8 | 0.34 |
| History hyperlipidemia (%) | 21.4 | 19.7 | 0.39 |
| History hypertension (%) | 66.4 | 65.6 | 0.73 |
| Smoking (%) | 42.2 | 49.1 | 0.00* |
| High Alcohol consumption (%) | 3.9 | 4.2 | 0.80 |
| History cardiac disease (%) | 22.7 | 21.9 | 0.71 |
| Personal stroke history (%) | 23.2 | 23.4 | 0.91 |
| SBP at admission, mmHg, (mean±SD) | 151.5±23.9 | 151.8±23.2 | 0.79 |
| DBP at admission, mmHg, (mean±SD) | 89.1±14.4 | 88.5±12.8 | 0.33 |
| NIHSS at admission, median(IQR) | 4(2–7) | 4(2–8) | 0.20 |
| Ischemic stroke (%) | 83.8 | 77.7 | 0.00* |
| Intravenous thrombolysis (%) | 1.9 | 2.5 | 0.37 |
| Anti-coagulation (%) | 14.4 | 16.5 | 0.21 |
| Anti-hypertension (%) | 57.2 | 54.1 | 0.20 |
| Anti-platelet (%) | 81.4 | 74.7 | 0.00* |
| Lower lipid drug (%) | 58.3 | 56.2 | 0.37 |
| Lower blood glucose drug (%) | 25.0 | 26.5 | 0.47 |
| Stroke education (%) | 84.5 | 88.5 | 0.01* |
| anti-depressant drugs at 2 weeks(%) | 5.8 | 8.1 | 0.00* |
| PSD at 2 weeks(%) | 28.1 | 31.4 | 0.12 |
SD indicates standard deviation; IQR, inter-quartile range; NIHSS, national institutes of health stroke scale; PSD, poststroke depression; SBP, Systolic blood pressure; DBP, Diastolic blood pressure.
*
indicates significant in statistics.